
4.35 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 2.57 Today|||52-Week Range 11.00 | +38.54% Year-to-Date |
The 4 analysts offering 12-month price forecasts for Interpace Biosciences Inc have a median target of 9.40, with a high estimate of 12.00 and a low estimate of 6.00. The median estimate represents a +116.09% increase from the last price of 4.35.
The current consensus among 4 polled investment analysts is to Buy stock in Interpace Biosciences Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.